EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma

Sung Uk Lee, Tae Hyun Kim, Sang Myung Woo, Jung Won Chun, Hyunjae Shin, Yu Ri Cho, Bo Hyun Kim, Young-Hwan Koh, Sang Soo Kim, Yang-Gun Suh, Sung Ho Moon, Woo Jin Lee

Cancer Research and Treatment · 2025

DOI: 10.4143/crt.2024.805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Sung Uk Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Proton Therapy Center, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Proton Therapy, Cholangiocarcinoma, Bile Duct Neoplasms, Chemoradiotherapy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to assess the clinical outcomes of hypofractionated proton beam therapy (PBT) for extrahepatic cholangiocarcinoma (EHCC) and to investigate the optimal sequencing for combining PBT with chemotherapy.Materials and Methods We retrospectively analyzed 59 consecutive patients with inoperable EHCC treated with PBT. The median prescribed dose of PBT was 50 GyE (range, 45 to 66 GyE) in 10 fractions. The combination sequences of PBT and chemotherapy were categorized as ‘Pre-PBT chemo’ (chemotherapy before PBT), ‘Post-PBT chemo’ (chemotherapy after PBT), and ‘No pre-/post-PBT chemo’ (no chemotherapy before or after PBT). Overall survival (OS), progression-free survival (PFS), and local PFS were estimated using the Kaplan-Meier method.

Results

All patients completed the planned treatments without any interruptions, and ≥ grade 3 acute adverse events were noted in 1.6% of the cases. The 1-year and 2-year freedom from local progression (FFLP) rates were 86.1% and 66.4%, respectively, with a median time of FFLP of 30.9 months. The 1- and 2-year OS rates were 74.5% and 25.3%, respectively, with a median survival time of 16.7 months. For prognostic factor analysis, pre- or post-PBT chemo was associated with a significantly reduced hazard ratio of 0.473 (95% confidence interval, 0.233 to 0.959; p=0.038) in the multivariate analysis. The median OS times for the groups receiving no pre-/post-PBT chemo, pre-PBT chemo, and post-PBT chemo were 14.6, 18.2, and 21.8 months, respectively (p < 0.05 for each).

Conclusion

Hypofractionated PBT for inoperable EHCC has demonstrated promising FFLP and OS rates with a safe toxicity profile. The combination of PBT with chemotherapy shows potential to improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyCholangiocarcinomaBile Duct NeoplasmsChemoradiotherapyAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleMiddle AgedAgedRetrospective StudiesRadiation Dose HypofractionationTreatment OutcomeAdultAged, 80 and over

Stichwörter der Autor:innen

Bile ductsCholangiocarcinomaExtrahepaticProton therapy

Autor:innen und Institutionen

  • Center for Proton Therapy Center, National Cancer Center, Goyang, Korea.
  • Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.

Förderung

  • National Cancer Center

Zitieren

APA

Lee, S. U., Kim, T. H., Woo, S. M., Chun, J. W., Shin, H., Cho, Y. R., Kim, B. H., Koh, Y. H., Kim, S. S., Suh, Y. G., Moon, S. H., & Lee, W. J. (2025). Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.805

Vancouver

Lee SU, Kim TH, Woo SM, Chun JW, Shin H, Cho YR, et al. Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma. Cancer Research and Treatment. 2025. doi:10.4143/crt.2024.805

BibTeX
@article{Lee2025,
  author = {Lee, Sung Uk and Kim, Tae Hyun and Woo, Sang Myung and Chun, Jung Won and Shin, Hyunjae and Cho, Yu Ri and Kim, Bo Hyun and Koh, Young-Hwan and Kim, Sang Soo and Suh, Yang-Gun and Moon, Sung Ho and Lee, Woo Jin},
  title = {Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma},
  journal = {Cancer Research and Treatment},
  year = {2025},
  doi = {10.4143/crt.2024.805}
}
Kostenlos starten →